ORLY vs STRO · P/E 34, rev $16.71B vs rev $62.0M
O’Reilly Automotive Inc (ORLY) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
O’Reilly Automotive Inc (ORLY) is a auto parts company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ORLY revenue for 2024-12-31 was $16.71B. Net income was $2.39B. Revenue was up 336.0% from 2023-12-31 to 2024-12-31. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ORLY currently screens at market cap $78.32B and trailing P/E 33.7. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ORLY and STRO stock pages for the full models.
Not investment advice.